Application
VCIP1 Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the VCIP1 antibody detected the VCIP1 protein (arrow).| Product Name | VCIP1 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA1850, VCIP135 |
|---|---|
| Alternative Names | VCPIP1 KIAA1850 VCIP135 Deubiquitinating protein VCIP135 Valosin-containing protein p97/p47 complex-interacting protein 1 Valosin-containing protein p97/p47 complex-interacting protein p135 |
| Molecular Weight(MW) | 134321 Da |
| Function | Acts as a deubiquitinating enzyme. Necessary for VCP- mediated reassembly of Golgi stacks after mitosis. May play a role in VCP-mediated formation of transitional endoplasmic reticulum (tER). Mediates dissociation of the ternary complex containing STX5A, NSFL1C and VCP (By similarity) |
| Tissue Specificity | This VCIP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 123-151 amino acids from the N-terminal region of human VCIP1. |
| Cellular Localization | Endoplasmic reticulum (By similarity). Golgi apparatus, Golgi stack (By similarity). Note=Associated with Golgi stacks and endoplasmic reticulum (By similarity) |
| Entrez Gene | 80124 |
|---|---|
| Nucleotide Accession | NP_079330.2 |
Application
VCIP1 Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the VCIP1 antibody detected the VCIP1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
